Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 210
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Do human activities increase antibiotic-resistant disease in Chilean penguins?

Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...

Backer Badge Funded